Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Wen Chen (Prolanta Inventor)
He also invented Somavert which is known as G120R. Somavert was successfully brought through trials obtaining FDA approval and is now sold on the market by Pfizer. Somavert (G120R) is a growth hormone receptor antagonist. This drug was able to successfully inhibit growth hormone receptors to help patients who have growth hormone disorders.
Prolanta also known as G129R is Wen Chens other invention. He developed both G120R and G129R around the same time period using the exact same amino acid substitution method. These drugs are almost identical to each other. The other interesting fact is that the structure of prolactin is similar to that of growth hormone and placental lactogen.
So here you have 2 identical drugs that are antagonists for 2 hormones that are very structurally similar to each other. Inhibiting human prolactin may be effective in antitumor activity because of its role in the presence and growth of cancerous tumors. The other issue with human prolactin hormones is that they also contribute to humans becoming resistant to chemotherapy. If you can antagonize the human prolactin receptors and hormone, you can at the very least increase the efficacy of chemotherapy, which in itself would be a major breakthrough.
So in conclusion, knowing that we have 2 almost identical drugs working to antagonize structurally similar hormones, we can hypothesize that both would be almost equally effective. One drug, Somavert, has already achieved FDA approval, and the other drug, Prolanta, has a strong probability to follow suit.
IMO
Oh really? The amendments outlined and detailed this scam in an official SEC document and everyone is okay with it?
It says 'estimated' study completion date is January 2018. That doesn't qualify as a 'cut off'. Oncolix will not be forced to give a trial update until April 2018 as they are required to provide updates at least once in a 12 month period. So there's your 'cut off', not January 2018.
The study and those dates were set up long before the company decided to reverse merge into AEPP. And... they had a lot more than 3 patients enrolled and tested on. There's only 3 listed in Phase I because that's the total number of patients that they were able to complete the study on due to a shortage in Prolanta from the manufacturer.
The study will be resuming shortly as Oncolix has the cash on hand to continue it's efforts.
Money makes the world go round. Nothing is free.
All false.
If Oncolix is to show some promising data after the completion of Phase I, it's a good possibility that they will partner with a larger pharmaceutical company. If this were to happen, you can eliminate any and all worries regarding whether or not they will be able to obtain adequate financing going into the future. The other possibility is a buyout, which in my opinion is the best case scenario.
Here's an article talking about the trend of smaller pharmas partnering with larger pharmas:
https://www.google.com/amp/s/www.forbes.com/sites/genemarcial/2015/07/12/partnerships-rather-than-buyouts-may-become-big-pharmas-choice-in-collaborating-with-biotechs/amp/
The only way Oncolix is going to need more cash is if they are able to make it through phase I and onto phase II. That would also mean that the company received positive data, and as we have seen with similar stocks, can be a major catalyst. So Oncolix needing more cash in the future can actually be seen as a good thing. Also, another thing we need go think about, is if the PPS runs up enough from positive phase I data, the less shares that Oncolix will need to sell in order get the necessary funding.
For example, if Oncolix were to need $5m in funding right now, they would have to sell 80m-100m shares, which would hurt the OS pretty badly. If the share price were to run up to say $1 on Phase I catalyst, they would only need to sell 5m-6m shares which is barely putting a chink in the armour. Don't quote my math as I know that the formula for issuing shares isn't so simple with discounted conversion prices, anti-dilution provisions, and whatever other terms are usually seen in financing.
If we get a positive Phase I catalyst, I'm planning to liquidate the majority of my position and ride a small amount of freebies off into the sunset.
I think Oncolix will have enough cash to get through Phase I, and if the data is good, it's not going to matter what the company does for a little while after that.
IMO
Happy thanksgiving to you too and to Molee, Reaper, Zen, Blight, Airstock, Namtae, Laraz, Tmcfo, steadyhand, Rat Fink, catfishhunter, ninersax, arbytrader, sungod, eltp, altjactup, heyhey44, bored lawyer, maro1, DayDreeming, microcaptrdr, ddninja, bw, pinky, ahtrader, blackdoggie, trade_trigger, and to whoever else I may have missed.
I hope everyone has a wonderful and safe holiday!
Hahaha yeah that's a good point. The most a stock can drop is more like 99.999999999%. Now if it were to get completely delisted I'm sure you could call it 100%.
That's funny because this stock is still up 840% from the time it was first known that Oncolix would be the majority shareholder and likely merging into AEPP. You'd be hard pressed to find other stocks holding 840% gains for as long as this has.
This is the kind of DD this board needs! Someone please sticky this post!
This is actually a great example of why Oncolix is so legit. Severance agreements are put into place because Redman no longer has job security. With the company being public and having actual board members who have voting rights, if they don't like the direction the company is going, they can force him out. Redman has the severance agreement which will allow him to receive compensation for a given period of time while he looks for a new job if he were to be terminated.
Redman has to be careful and do what's in the best interest of the company and stockholders/board members who have controlling interests and voting rights. You won't find other OTC CEO's with a severance agreement because they are usually the be all and end all with no one to oppose them.
This agreement lends even more credibility to Oncolix not even being remotely close to a scam.
Thanks for sharing.
No one wants a CEO that owns multiple sub penny OTC pink companies. That to me looks sketchy and a major deterrent. And how do we know the other guy is a nobody? Do you realize how hard it is to do research on Chinese business?
It's not even the same CEO!? Lololol
They have different names.
Not so sure about that. Went to the OTC Markets page for each company and they are different names. Also, one is from Malaysia and the other is from Hong Kong.
It's advanced trader terminology.
Novartis can't even touch Prolanta without infringing upon Oncolix' patents.
So are you saying that Novartis stole their drug and tested it without them knowing it, but somehow you know about this?
I've heard some really stupid things, but this one takes the cake!!
Where is the filing showing that 450m shares are being issued and added to the OS? I can only find the one where they are being added to the AS, which means that they aren't going to flood the market, at least not any time soon. Authorized shares do not need to be used and cannot crush the price down to .005 until they've been issued and converted on the open market.
Please help me find your sources that back your statement.
TIA
Also, this isn't the first public biopharma that Redman has been the CEO of. He's not a rookie executive. He's been around the block and I'm sure he knows what he's doing.
Not to mention that Wen Chen who is an advisor to Oncolix and the inventor of Prolanta, has already contributed to a drug that went from infancy, through all the trial phases, and on to an FDA approval.
Here's the screenshot of the email:
https://imgur.com/gallery/OdEU8
I don't have PM btw.
Imagine writing something that was actually factual?
All of the DD and SEC filings point to the most legit company and merger currently in the OTC Pink and soon to be on the OTC QB. The research and development DD behind their main attraction Prolanta through all of it's studies, lab tests, publications, and patents point to a 100% legitimate drug and company.
I just tried calling FINRA and they will not give out any information regarding the ticker change. So that's that I guess. At least I got an encouraging email response from Redman.
Redman email response:
"In general, it takes about 30 days to get the ticker change. We filed about three weeks ago. The Thanksgiving holiday is another factor. It should be soon. We have a lot of other announcements forthcoming after the ticker change."
Who knows, but it might not hurt to try.
Has anyone tried calling FINRA to verify that they have all the paperwork and possibly get a timeframe for its completion?
Everything has been filed and it's just a matter of FINRA completing things on their end correct?
You didn't know about the 3 person stock test?
Well if you're day trading or swing trading, this might not be a good stock for you as there might not be any major catalysts in the short term to support it. But then again, the market can be unpredictable and we have no idea what Oncolix will do or how investors will react. I'm more than willing to see this through 2018 and in to 2019. I have been in this since March/April and can keep patiently holding for as long as needed. It would be nice to hold this for some long term cap gains.
Not worried because if they are able to get to a point where they need additional funding for say Phase II trials, I believe the interest here will be strong enough to chew through the dilutive shares.
IMO
Authorized shares do not hit the market until they've been issued. They may never even have to use those extra authorized shares.
What do you think about companies on the Nasdaq that have billions of authorized shares?
Yeah but it's pretty hard to hide a scam when there are so many parties involved here. And what scam could they possibly be running? Producing fake cancer treatments? We know they aren't fake because someone has to manufacture and test the drugs. The FDA certainly has its hand in this, I mean they do have orphan drug status.
Seems like it would be very easy to sniff out this purported scam. Most OTC companies do not have the level of involvement with legtitmate third parties like Oncolix does. So with that being said, it would be extremely unlikely that a scam of any kind is happening here. Oncolix is as legit as they come and the only thing investors here should be worried about is the efficacy of Prolanta and the development of their pipeline.
JMO
I could be wrong, but as you move to higher exchanges, don't MM's and institutional investors have more of an impact on stock movement?
Stocks in the OTC go from 'zero interest' to major volume at the flip of a switch all the time. All it takes is a catalyst. You've never seen a dormant ticker just all of sudden wake up? It tends to happen more so with legitimate company's, which in my opinion, Oncolix falls into that category based on my own DD.
And you really think that MTR and JDP would be like "Hey let's run a cancer patient scam that is so easy to figure out, that Ihub members didn't even have to do any DD to figure it out."
If you can so "clearly" see this "scam", then the SEC and FED's can "clearly" see it too. So they are turning a blind eye to it? Or everyone is just too stupid to realize what is happening?
Why would they run a scam that's so "easy" for you to see, that could put them in jail for 25+ years? Doesn't seem like a smart move. I have my doubts about the "scam" theory.
IMO
And by the way, AEPP is no longer an "empty shell". I'm assuming you haven't looked at the last Q or otherwise you wouldn't have made that statement.
IMO
Talking to crocodiles for advice really does explain a lot. Everything is starting to make sense now.
That's what it looks like on Twitter. I'm not in this stock and haven't been following things.
Shareholder letter is out. No plans for reverse split.
Haha that's the best you can come up with!?
For anyone who doesn't believe this post and that a phone call to ITOR/GHS took place, here is a screenshot of my outgoing phone call. Notice the date and the number?
https://imgur.com/gallery/zidFd